INVA Innoviva, Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$20.50
· of 52w range
· above low
· to high
$16.5252w low
$25.1552w high
Market Cap (MRQ)
$1.49B
P/E (TTM)
4.7
EPS (TTM)
$4.35
Revenue (TTM)
$440M
your badges
52W Range
$17–$25
Analyst Rating
BUY
Price Target
$35
P/E
4.7
ROE
36.7%
Net Profit Margin
81.2%
Your badge strip is empty — pin a metric anywhere on this page.
INVA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$20.50
Market Cap (MRQ)
$1.49B
P/E (TTM)
4.7
EPS (TTM)
$4.35
Revenue (TTM)
$440M
ROE (TTM)
36.7%
Debt/Equity (MRQ)
0.2
52W Range
$17–$25
INVA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 3, 2014 | 1241-for-1000 | Forward |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$411M2016-12-31 → 2025-12-31
EPS$3.302016-12-31 → 2025-12-31
Free Cash Flow·2016-12-31 → 2021-12-31
Net margin81.2%2017-12-31 → 2021-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | INVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 4.75Y avg ≈14.6 | ≈14.6 | 12.9 | Undervalued | |
| P/S (TTM) | 3.4 | · | 6.9 | Undervalued | |
| P/B (MRQ) | 1.2 | · | 3.9 | Undervalued | |
| Price / FCF (TTM) | 7.9 | · | · | · | |
| Price / Cash Flow (TTM) | 7.8 | · | 26.5 | Undervalued | |
| Price / Tangible Book (MRQ) | 1.45Y avg ≈2.3 | ≈2.3 | · | · | |
| PEG Ratio | ≈0.5 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | INVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 72.2% | · | · | · | |
| Operating Margin (TTM) | 36.9% | · | 5.6% | Top tier | |
| Pretax Margin (TTM) | 95.3% | · | 13.9% | Weak | |
| Net Profit Margin (TTM) | 81.2% | · | -13.6% | Weak | |
| ROA (TTM) | 23.5% | · | -0.47% | Top tier | |
| ROE (TTM) | 36.7% | · | -8.2% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | INVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.2 | · | 0.4 | Low debt | |
| Current Ratio (MRQ) | 16.0 | · | 2.9 | Strong liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.2 | · | 0.4 | Low debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | INVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 14.7%5Y avg ≈5.0% | ≈5.0% | · | · | |
| Revenue CAGR 3Y | 7.5%5Y avg ≈0.63% | ≈0.63% | · | · | |
| Revenue CAGR 5Y | 4.1% | · | · | · | |
| EPS YoY | 816.7%5Y avg ≈150.1% | ≈150.1% | · | · | |
| Net Income YoY | 1059.2%5Y avg ≈187.8% | ≈187.8% | · | · | |
| EPS CAGR 3Y | 11.7%5Y avg ≈-11.8% | ≈-11.8% | · | · | |
| EPS CAGR 5Y | 10.3% | · | · | · | |
| Net Income CAGR 3Y | 7.2%5Y avg ≈-22.7% | ≈-22.7% | · | · | |
| Net Income CAGR 5Y | -1.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | INVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$2.6M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Annualized Payout≈$1.00
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Sep 8, 2015 | $0.25 | USD | ≈7.4% |
| Jun 10, 2015 | $0.25 | USD | ≈5.5% |
| Mar 10, 2015 | $0.25 | USD | ≈3.8% |
| Nov 21, 2014 | $0.25 | USD | ≈3.6% |
| Aug 26, 2014 | $0.25 | USD | ≈1.1% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-67.1%
Next Report
Nov 03, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 4, 2026 | $-1.14 | $0.44 | -356.4% |
| March 31, 2026 | May 13, 2026 | $-0.05 | $0.40 | -112.6% |
| Dec. 31, 2025 | $1.94 | $0.56 | 245.8% | |
| Sept. 30, 2025 | $1.08 | $0.49 | 119.4% | |
| June 30, 2025 | $0.77 | $0.51 | 51.0% | |
| March 31, 2025 | $-0.74 | $0.30 | -350.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $411M | $359M | $310M | $331M | $392M | $337M | $261M | $261M | $217M | $134M | $54M | $8M | |
| Gross Profit | $308M | $296M | $246M | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $31M | $14M | $34M | $41M | $576.0K | $2M | $0 | $0 | $1M | $1M | $3M | $7M | |
| SG&A Expense | $113M | $116M | $98M | $64M | $16M | $14M | $15M | $20M | $32M | $23M | $20M | $35M | |
| Operating Expenses | $144M | $129M | $132M | $44M | $-53M | $-17M | $15M | $23M | $34M | $25M | $22M | $42M | |
| Operating Income | $164M | $167M | $114M | · | $375M | $321M | $246M | $238M | $184M | $109M | $32M | $-34M | |
| Interest Expense | $17M | $22M | $19M | $16M | $19M | $18M | $19M | $24M | $44M | $52M | $52M | $37M | |
| Interest Income | $21M | $19M | $16M | $6M | $2M | $2M | $6M | · | · | · | · | · | |
| Other Non-op | $-3M | $-3M | $-5M | $-3M | $-4M | $-348.0K | $-345.0K | $-6M | $-7M | $2M | $1M | $-3M | |
| Pretax Income | $327M | $37M | $194M | $287M | $445M | $354M | $233M | $210M | $134M | $60M | $-19M | $-74M | |
| Income Tax | $56M | $14M | $14M | $67M | $76M | $60M | $42M | $-196M | $4.0K | $95.0K | $0 | $0 | |
| Net Income | $271M | $23M | $180M | $220M | $369M | $294M | $191M | $406M | $134M | $60M | $-19M | · | |
| EPS (Basic) | $4.02 | $0.37 | $2.75 | $3.07 | $3.24 | $2.21 | $1.55 | $3.92 | $1.25 | $0.54 | $-0.16 | $-1.50 | |
| EPS (Diluted) | $3.30 | $0.36 | $2.20 | $2.37 | $2.87 | $2.02 | $1.43 | $3.53 | $1.17 | $0.53 | $-0.16 | $-1.50 | |
| Shares (Basic) | 67,395,000 | 62,726,000 | 65,435,000 | 69,644,000 | 82,062,000 | 101,320,000 | 101,150,000 | 100,849,000 | 106,945,000 | 110,280,000 | 115,372,000 | 112,059,000 | |
| Shares (Diluted) | 84,760,000 | 74,187,000 | 86,876,000 | 95,248,000 | 94,310,000 | 113,554,000 | 113,409,000 | 113,408,000 | 119,866,000 | 123,233,000 | 115,372,000 | 112,059,000 | |
| EBITDA | · | · | · | · | $389M | $335M | · | $252M | $198M | $123M | $46M | $-22M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $551M | $305M | $194M | $291M | $202M | $246M | $278M | $62M | $73M | $118M | $159M | $97M | |
| Short-term Investments | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Inventory | $39M | $34M | $41M | $56M | $0 | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $27M | $21M | $22M | $30M | $1M | $2M | $962.0K | $849.0K | $754.0K | $766.0K | $814.0K | $1M | |
| Other Current Assets | $2M | $656.0K | $4M | $3M | $70.0K | · | · | · | · | · | · | · | |
| Current Assets | $728M | $554M | $344M | $444M | $314M | $342M | $431M | $199M | $200M | $198M | $214M | $252M | |
| PP&E (Net) | $2M | $514.0K | $483.0K | $170.0K | $12.0K | $28.0K | $33.0K | $160.0K | $209.0K | $368.0K | $221.0K | $324.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $324.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Goodwill | $18M | $18M | $18M | $27M | $0 | · | · | · | · | · | · | · | |
| Intangibles | $182M | $208M | $230M | $253M | $0 | · | · | · | · | · | · | · | |
| Other Non-current Assets | $41M | $41M | $3M | $4M | $11.0K | $214.0K | $312.0K | $37.0K | $37.0K | $37.0K | $18.0K | $18M | |
| Total Assets | $1.64B | $1.30B | $1.24B | $1.23B | $926M | $1000M | $725M | $548M | $367M | $379M | $409M | $522M | |
| Accounts Payable | $5M | $2M | $7M | $3M | $27.0K | $66.0K | $10.0K | $11.0K | $601.0K | $128.0K | $818.0K | $0 | |
| Current Liabilities | $50M | $236M | $38M | $135M | $6M | $6M | $5M | $6M | $35M | $20M | $13M | $14M | |
| Capital Leases | $11M | $1M | $2M | $2M | $0 | · | · | $0 | · | · | · | · | |
| Deferred Tax | $32M | $0 | $563.0K | $6M | $0 | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $66M | $64M | $72M | $71M | $0 | $106.0K | $219.0K | $586.0K | $940.0K | $1M | $2M | $2M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $716M | $748M | $726M | |
| Total Debt | · | · | · | · | $395M | $386M | · | $383M | $574M | $716M | · | · | |
| Common Stock | $747.0K | $627.0K | $633.0K | $692.0K | $696.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Retained Earnings | $269M | $-2M | $-25M | $-205M | $-456M | $-722M | $-946M | $-1.10B | $-1.50B | $-1.63B | $-1.69B | $-1.67B | |
| Treasury Stock | · | $0 | $394M | $394M | $394M | $0 | · | $0 | $3M | $3M | $3M | $3M | |
| AOCI | · | · | · | · | · | $0 | $27.0K | $-3.0K | $-18.0K | $1.0K | $-2.0K | $-87.0K | |
| Stockholders' Equity | $1.17B | $691M | $675M | $566M | $526M | $608M | $313M | $154M | $-243M | $-353M | $-343M | $-223M | |
| Liabilities + Equity | $1.64B | $1.30B | $1.24B | $1.23B | $926M | $1000M | $725M | $548M | $367M | $379M | $409M | $522M | |
| Shares Outstanding | 74,636,000 | 62,665,000 | 63,307,000 | 69,188,000 | 69,566,000 | 101,392,000 | 101,288,000 | 101,098,000 | 102,046,000 | 108,585,000 | 114,933,000 | 116,445,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $12M | |
| Stock-based Comp | $9M | $6M | $6M | $7M | $2M | $2M | $2M | $3M | $10M | $8M | $7M | $27M | |
| Deferred Tax | $44M | $-13M | $4M | $25M | $76M | $60M | $42M | $-196M | $0 | $0 | · | · | |
| Amort. of Intangibles | $26M | $26M | $22M | $6M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | $-97M | $-57M | · | $-4M | $-16M | · | · | · | |
| Operating Cash Flow | $197M | $189M | $141M | $202M | $364M | $313M | $257M | $224M | $142M | $61M | $10M | $-131M | |
| CapEx | $1M | $270.0K | $411.0K | $67.0K | $0 | $13.0K | $12.0K | $0 | $0 | $278.0K | $7.0K | $689.0K | |
| Investing Cash Flow | $40M | $-64M | $-67M | $-57M | $44M | $-315M | $-18M | $4M | $-23M | $-5M | $159M | $-65M | |
| Stock Issued | $3M | $1M | $170.0K | $370.0K | $1M | $436.0K | $627.0K | $1M | $435.0K | $385.0K | $8M | $55M | |
| Stock Repurchased | $5M | $15M | $76M | $9M | $394M | $0 | $0 | $0 | $98M | $78M | $26M | $0 | |
| Net Stock Activity | · | · | · | · | $-393M | $436.0K | · | $1M | $-97M | $-78M | $-20M | $49M | |
| Dividends Paid | · | · | · | · | $0 | $0 | $11.0K | $80.0K | $281.0K | $960.0K | $87M | $57M | |
| Financing Cash Flow | $9M | $-13M | $-172M | $-56M | $-452M | $-30M | $-24M | $-238M | $-163M | $-98M | $-107M | $149M | |
| Net Change in Cash | $246M | $111M | $-98M | $90M | $-45M | $-32M | $216M | $-11M | $-45M | $-41M | $62M | $-47M | |
| Taxes Paid | $19M | $12M | $0 | $54M | $0 | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $364M | $313M | · | $224M | $142M | $61M | $10M | $-131M | |
| Levered FCF | · | · | · | · | $348M | $298M | · | $177M | · | · | $-42M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 95.7% | 95.3% | · | 91.3% | 84.5% | 81.6% | 58.5% | -402.3% | |
| Net Margin | · | · | · | · | 94.1% | 87.2% | · | 155.7% | 61.8% | · | · | · | |
| Pretax Margin | · | · | · | · | 113.6% | 105.2% | · | 80.6% | · | 44.6% | -34.8% | · | |
| EBITDA Margin | · | · | · | · | 99.2% | 99.5% | · | 96.6% | 91.0% | 92.0% | 84.4% | -258.0% | |
| ROA | · | · | · | · | 38.3% | 34.1% | · | 88.8% | 36.0% | · | · | · | |
| ROE | · | · | · | · | 72.1% | 68.9% | · | -910.3% | -45.1% | · | · | · | |
| ROIC | · | · | · | · | 38.4% | 28.8% | · | 85.8% | · | · | -9.2% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 54.0 | 56.0 | · | 34.9 | 5.8 | 9.9 | 15.9 | 18.3 | |
| Quick Ratio | · | · | · | · | 34.7 | 40.3 | · | 11.0 | 2.1 | 5.9 | 11.8 | 7.0 | |
| Debt / Equity | · | · | · | · | 1.0 | 0.7 | · | 2.5 | -2.4 | -2.0 | · | · | |
| LT Debt / Equity | · | · | · | · | 1.0 | 0.7 | · | 2.5 | -2.4 | -2.0 | · | · | |
| Interest Coverage | · | · | · | · | 19.7 | 17.5 | · | 9.9 | 4.2 | 2.1 | 0.6 | -0.9 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.4 | 0.4 | · | 0.6 | 0.6 | 0.3 | 0.1 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 84.8 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | $5.96 | $5.33 | · | $1.52 | $-2.38 | $-3.25 | $-2.98 | · | |
| Revenue / Share | · | · | · | · | $4.16 | $2.97 | · | $2.30 | $1.81 | $1.08 | · | · | |
| Cash Flow / Share | · | · | · | · | $3.86 | $2.76 | · | $1.97 | $1.18 | $0.49 | · | · | |
| Cash / Share | · | · | · | · | $2.90 | $2.43 | · | $0.62 | $0.72 | $1.09 | $1.39 | · | |
| Dividend / Share | · | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.75 | $0.50 | |
| EPS (TTM) | $3.30 | $0.36 | $2.20 | $2.37 | $2.87 | $2.02 | $1.43 | $3.53 | $1.17 | $0.53 | $-0.16 | $-1.50 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 14.7% | 15.5% | -6.3% | -15.4% | 16.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.5% | -2.9% | -2.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 816.7% | -83.6% | -7.2% | -17.4% | 42.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 11.7% | -49.9% | 2.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1059.2% | -87.0% | -18.4% | -40.3% | 25.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 7.2% | -60.1% | -15.1% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -1.6% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $411M | $359M | $310M | $331M | $392M | $337M | $261M | $261M | $217M | $134M | $54M | $8M | |
| Net Income TTM | $271M | $23M | $180M | $220M | $369M | $294M | $191M | $406M | $134M | $60M | $-19M | · | |
| Market Cap | · | · | · | · | $1.20B | $1.26B | · | $1.76B | $1.45B | $1.16B | $1.21B | · | |
| Enterprise Value | · | · | · | · | $1.39B | $1.40B | · | $2.08B | $1.95B | $1.76B | · | · | |
| P/E | 6.1 | 48.2 | 7.3 | 5.6 | 6.0 | 6.1 | 9.9 | 4.9 | 12.1 | 20.2 | -65.9 | -9.4 | |
| P/S | · | · | · | · | 3.1 | 3.7 | · | 6.8 | 6.7 | 8.7 | 22.5 | · | |
| P/B | · | · | · | · | 2.9 | 2.3 | · | 11.5 | -6.0 | -3.3 | -3.5 | · | |
| P / Tangible Book | 1.5 | 2.3 | 2.4 | 3.2 | 2.3 | 2.1 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | · | 3.3 | 4.0 | · | 7.9 | 10.2 | 19.1 | 119.6 | · | |
| P / FCF | · | · | · | · | 3.3 | 4.0 | · | 7.9 | 10.2 | 19.1 | 119.7 | · | |
| EV / EBITDA | · | · | · | · | 3.6 | 4.2 | · | 8.3 | 9.9 | 14.3 | · | · | |
| EV / FCF | · | · | · | · | 3.8 | 4.5 | · | 9.3 | 13.8 | 29.0 | · | · | |
| EV / Revenue | · | · | · | · | 3.6 | 4.1 | · | 8.0 | 9.0 | 13.2 | · | · | |
| Dividend Yield | · | · | · | · | 0.00% | 0.00% | · | 0.00% | 0.02% | 0.08% | 7.2% | · | |
| Earnings Yield | 16.5% | 2.1% | 13.7% | 17.9% | 16.6% | 16.3% | 10.1% | 20.2% | 8.2% | 5.0% | -1.5% | -10.6% | |
| Payout Ratio | · | · | · | · | 0.00% | 0.00% | · | 0.02% | 0.21% | · | · | · | |
| Annual Payout | · | · | · | · | $0 | $0 | $11.0K | $80.0K | $281.0K | $960.0K | $87M | $57M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $120M | $98M | $115M | $108M | $100M | $89M | $92M | $90M | $100M | $77M | $86M | $67M | $81M | $76M | $66M | $67M | |
| Gross Profit | $91M | $76M | $76M | $76M | $83M | $73M | $78M | $73M | $85M | $60M | · | · | · | · | · | · | |
| R&D Expense | $5M | $5M | $5M | $14M | $8M | $4M | $4M | $4M | $3M | $4M | $2M | $4M | $15M | $13M | $10M | $12M | |
| SG&A Expense | $35M | $32M | $32M | $27M | $26M | $27M | $31M | $26M | $28M | $30M | $26M | $29M | $24M | $20M | $17M | $28M | |
| Operating Expenses | $40M | $38M | $37M | $41M | $34M | $32M | $35M | $30M | $30M | $34M | $40M | $-19M | $75M | $35M | $130M | $-219M | |
| Operating Income | $51M | $38M | $39M | $35M | $49M | $41M | $43M | $43M | $55M | $26M | · | · | · | · | · | · | |
| Interest Expense | $5M | $5M | $3M | $4M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $4M | $4M | $4M | $4M | $5M | |
| Interest Income | $8M | $11M | $6M | $5M | $5M | $5M | $6M | $6M | $3M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Other Non-op | $-15.0K | $-366.0K | $-612.0K | $-479.0K | $-777.0K | $-996.0K | $126.0K | $-914.0K | $-973.0K | $-1M | $-680.0K | $-1M | $-2M | $-1M | $-3M | $28.0K | |
| Pretax Income | $-108M | $235M | $195M | $98M | $73M | $-39M | $25M | $7M | $-39M | $45M | $61M | $86M | $6M | $41M | $-65M | $286M | |
| Income Tax | $-25M | $48M | $31M | $8M | $9M | $8M | $4M | $6M | $-5M | $9M | $-330.0K | $4M | $5M | $6M | $4M | $57M | |
| Net Income | $-83M | $187M | $164M | $90M | $64M | $-47M | $20M | $1M | $-35M | $37M | $62M | $82M | $1M | $35M | $-68M | $229M | |
| EPS (Basic) | $-1.14 | $2.52 | $2.45 | $1.30 | $1.01 | $-0.74 | $0.32 | $0.02 | $-0.55 | $0.58 | $0.96 | $1.26 | $0.02 | $0.51 | $-0.98 | $3.81 | |
| EPS (Diluted) | $-1.14 | $2.22 | $2.19 | $1.08 | $0.77 | $-0.74 | $0.43 | $0.02 | $-0.55 | $0.46 | $0.78 | $0.98 | $0.02 | $0.42 | $-0.68 | $2.80 | |
| Shares (Basic) | 73,421,000 | 74,160,000 | · | 69,058,000 | 62,865,000 | 62,709,000 | · | 62,569,000 | 62,526,000 | 63,185,000 | · | 64,953,000 | 65,341,000 | 67,786,000 | · | 69,731,000 | |
| Shares (Diluted) | 73,421,000 | 84,849,000 | · | 84,964,000 | 84,452,000 | 62,709,000 | · | 62,951,000 | 62,526,000 | 84,531,000 | · | 86,164,000 | 65,489,000 | 89,788,000 | · | 95,830,000 | |
| EBITDA | $51M | $38M | · | $35M | $49M | $41M | · | · | · | · | · | · | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $570M | $603M | $551M | $477M | $398M | $319M | $305M | $261M | $217M | $178M | · | $180M | $173M | $144M | · | $301M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $282.0K | |
| Inventory | $39M | $39M | $39M | $38M | $49M | $41M | $34M | $34M | $37M | $37M | · | $41M | $47M | $50M | · | $71M | |
| Prepaid Expense | $24M | $25M | $27M | $19M | $17M | $15M | $21M | $13M | $8M | $17M | · | $15M | $21M | $24M | · | $8M | |
| Other Current Assets | $313.0K | $4M | $2M | $171.0K | $181.0K | $313.0K | $656.0K | $2M | $2M | $3M | · | $2M | $2M | $3M | · | $2M | |
| Current Assets | $753M | $773M | $728M | $685M | $652M | $582M | $554M | $401M | $358M | $311M | · | $305M | $324M | $296M | · | $455M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $451.0K | $483.0K | $514.0K | $544.0K | $427.0K | $324.0K | · | $361.0K | $161.0K | $180.0K | · | $165.0K | |
| Goodwill | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | · | $18M | $15M | $28M | · | $16M | |
| Intangibles | $169M | $176M | $182M | $189M | $195M | $202M | $208M | $211M | $217M | $224M | · | $237M | $243M | $248M | · | $258M | |
| Other Non-current Assets | $40M | $41M | $41M | $41M | $41M | $41M | $41M | $3M | $3M | $3M | · | $3M | $4M | $4M | · | $5M | |
| Total Assets | $1.70B | $1.84B | $1.64B | $1.43B | $1.33B | $1.25B | $1.30B | $1.23B | $1.22B | $1.27B | · | $1.19B | $1.12B | $1.13B | · | $1.33B | |
| Accounts Payable | $4M | $7M | $5M | $6M | $5M | $5M | $2M | $4M | $2M | $890.0K | · | $4M | $5M | $6M | · | $4M | |
| Current Liabilities | $47M | $37M | $50M | $48M | $247M | $235M | $236M | $224M | $28M | $30M | · | $36M | $39M | $38M | · | $164M | |
| Capital Leases | $10M | $11M | $11M | $905.0K | $1M | $1M | $1M | $2M | $2M | $1M | · | $2M | $2M | $2M | · | $3M | |
| Deferred Tax | $37M | $73M | $32M | · | · | · | $0 | $0 | $0 | $4M | · | $0 | $0 | $5M | · | · | |
| Other Non-current Liabilities | $67M | $69M | $66M | $57M | $60M | $62M | $64M | $71M | $72M | $72M | · | $69M | $69M | $70M | · | $78M | |
| Total Debt | $258M | $258M | · | $257M | $257M | $257M | · | $256M | $447M | $447M | · | $446M | $445M | $445M | · | $444M | |
| Common Stock | $727.0K | $738.0K | $747.0K | $748.0K | $630.0K | $628.0K | $627.0K | $626.0K | $626.0K | $628.0K | · | $644.0K | $653.0K | $659.0K | · | $698.0K | |
| Retained Earnings | $373M | $456M | $269M | $105M | $15M | $-48M | $-2M | $-22M | $-23M | $11M | · | $-87M | $-169M | $-170M | · | $-137M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $0 | $394M | · | $394M | $394M | $394M | · | $394M | |
| Stockholders' Equity | $1.23B | $1.34B | $1.17B | $1.01B | $715M | $647M | $691M | $669M | $666M | $704M | · | $627M | $555M | $561M | $566M | $641M | |
| Liabilities + Equity | $1.70B | $1.84B | $1.64B | $1.43B | $1.33B | $1.25B | $1.30B | $1.23B | $1.22B | $1.27B | · | $1.19B | $1.12B | $1.13B | · | $1.33B | |
| Shares Outstanding | 72,637,000 | 73,808,000 | 74,636,000 | 74,769,000 | 63,011,000 | 62,771,000 | 62,665,000 | 62,601,000 | 62,562,000 | 62,797,000 | 63,307,000 | 64,384,000 | 65,225,000 | 65,824,000 | 69,188,000 | 69,776,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Stock-based Comp | $5M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $4M | |
| Deferred Tax | $-36M | $41M | $40M | $5M | $-637.0K | $-240.0K | $3M | $-3M | $-15M | $3M | $6M | $-2M | $1M | $-812.0K | $-4M | $23M | |
| Amort. of Intangibles | $7M | $7M | $7M | $7M | $6M | $6M | $7M | $6M | $6M | $6M | $7M | $7M | $5M | $4M | $4M | $2M | |
| Operating Cash Flow | $52M | $35M | $55M | $50M | $44M | $49M | $59M | $49M | $44M | $37M | $33M | $44M | $38M | $26M | $9M | $16M | |
| CapEx | $429.0K | $492.0K | $10.0K | $1M | $0 | $0 | $0 | $270.0K | $0 | $0 | $151.0K | $227.0K | $0 | $33.0K | $34.0K | $11.0K | |
| Investing Cash Flow | $-55M | $37M | $24M | $18M | $33M | $-35M | $-15M | $-5M | $0 | $-43M | $-5M | $-26M | $0 | $-36M | $-9M | $98M | |
| Stock Issued | $2M | $259.0K | $838.0K | $194.0K | $1M | $250.0K | $592.0K | $229.0K | $157.0K | $488.0K | $59.0K | $0 | $111.0K | $0 | $28.0K | $1.0K | |
| Stock Repurchased | $31M | $20M | $5M | $0 | $0 | $0 | $0 | $0 | $5M | $10M | $15M | $11M | $9M | $41M | $9M | $0 | |
| Net Stock Activity | · | $-20M | · | · | · | $250.0K | · | · | · | $-9M | · | · | · | $-41M | · | · | |
| Financing Cash Flow | $-29M | $-20M | $-4M | $11M | $1M | $183.0K | $573.0K | $211.0K | $-5M | $-9M | $-15M | $-11M | $-9M | $-137M | $-10M | $-96M | |
| Net Change in Cash | $-33M | $52M | $74M | $79M | $78M | $14M | $44M | $44M | $39M | $-15M | $14M | $7M | $29M | $-147M | $-10M | $17M | |
| Taxes Paid | $12M | $670.0K | $6M | $1M | $12M | $0 | $0 | $12M | · | · | $0 | · | · | · | $50M | · | |
| Free Cash Flow | · | $35M | · | · | · | · | · | · | · | $37M | · | · | · | $26M | · | · | |
| Levered FCF | · | $30M | · | · | · | · | · | · | · | $32M | · | · | · | $22M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.8% | 77.4% | · | 70.1% | 82.9% | 82.7% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | 42.5% | 38.9% | · | 32.1% | 48.6% | 46.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -69.8% | 190.4% | · | 83.4% | 63.5% | -52.6% | · | 1.4% | -34.7% | 47.1% | · | 122.0% | 1.6% | 45.6% | · | 341.0% | |
| Pretax Margin | -90.3% | 239.4% | · | 90.7% | 72.4% | -43.5% | · | 7.6% | -39.3% | 58.2% | · | 127.8% | 7.2% | 53.9% | · | 425.9% | |
| EBITDA Margin | 42.5% | 38.9% | · | 32.1% | 48.6% | 46.7% | · | · | · | · | · | · | · | · | · | · | |
| ROA | -5.5% | 12.1% | · | 6.8% | 5.0% | -3.7% | · | 0.10% | -3.0% | 3.0% | · | 6.5% | 0.11% | 3.1% | · | 20.7% | |
| ROE | -8.6% | 18.8% | · | 10.7% | 9.2% | -6.9% | · | 0.19% | -5.7% | 5.8% | · | 12.9% | 0.27% | 7.3% | · | 43.9% | |
| ROIC | 2.6% | 1.9% | · | 2.5% | 4.4% | 5.5% | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.0 | 21.1 | · | 14.1 | 2.6 | 2.5 | · | 1.8 | 12.7 | 10.4 | · | 8.4 | 8.2 | 7.8 | · | 2.8 | |
| Quick Ratio | 12.1 | 16.5 | · | 9.8 | 1.6 | 1.4 | · | 1.2 | 7.7 | 6.0 | · | 5.0 | 4.4 | 3.8 | · | 1.8 | |
| Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.7 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.7 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | |
| Interest Coverage | 9.3 | 7.0 | · | 8.6 | 10.5 | 8.8 | · | · | · | · | · | · | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.98 | $18.18 | · | $13.51 | $11.34 | $10.31 | · | $10.68 | $10.64 | $11.21 | · | $9.75 | $8.51 | $8.53 | · | $9.19 | |
| Revenue / Share | $1.63 | $1.15 | · | $1.27 | $1.19 | $1.41 | · | $1.42 | $1.60 | $0.92 | · | $0.78 | $1.24 | $0.85 | · | $0.70 | |
| Cash Flow / Share | · | $0.42 | · | · | · | $0.78 | · | · | · | $0.44 | · | · | · | $0.29 | · | · | |
| Cash / Share | $7.85 | $8.17 | · | $6.37 | $6.31 | $5.08 | · | $4.16 | $3.47 | $2.84 | · | $2.80 | $2.65 | $2.19 | · | $4.31 | |
| EPS (TTM) | $4.35 | $6.26 | · | $1.54 | $0.48 | $-0.84 | · | $0.71 | $1.67 | $2.24 | · | $0.74 | $2.56 | $2.59 | · | $3.28 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $440M | $421M | · | $389M | $370M | $370M | · | $353M | $330M | $312M | · | $290M | $290M | $318M | · | $373M | |
| Net Income TTM | $357M | $504M | · | $127M | $39M | $-60M | · | $65M | $145M | $181M | · | $50M | $197M | $217M | · | $334M | |
| Market Cap | $1.65B | $1.72B | · | $1.36B | $1.27B | $1.14B | · | $1.21B | $1.03B | $957M | · | $836M | $830M | $741M | · | $810M | |
| Enterprise Value | $1.34B | $1.37B | · | $1.15B | $1.13B | $1.08B | · | $1.20B | $1.26B | $1.23B | · | $1.10B | $1.10B | $1.04B | · | $953M | |
| P/E | 5.2 | 3.7 | · | 11.9 | 41.9 | -21.6 | · | 27.2 | 9.8 | 6.8 | · | 17.6 | 5.0 | 4.3 | · | 3.5 | |
| P/S | 3.7 | 4.1 | · | 3.5 | 3.4 | 3.1 | · | 3.4 | 3.1 | 3.1 | · | 2.9 | 2.9 | 2.3 | · | 2.2 | |
| P/B | 1.3 | 1.3 | · | 1.4 | 1.8 | 1.8 | · | 1.8 | 1.5 | 1.4 | · | 1.3 | 1.5 | 1.3 | · | 1.3 | |
| P / Tangible Book | 1.6 | 1.5 | · | 1.7 | 2.5 | 2.7 | · | 2.7 | 2.4 | 2.1 | · | 2.2 | 2.8 | 2.6 | · | 2.2 | |
| P / Cash Flow | · | 48.7 | · | · | · | 23.4 | · | · | · | 25.8 | · | · | · | 28.8 | · | · | |
| EV / Revenue | 3.0 | 3.3 | · | 2.9 | 3.0 | 2.9 | · | 3.4 | 3.8 | 3.9 | · | 3.8 | 3.8 | 3.3 | · | 2.6 | |
| Dividend Yield | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | 0.00% | |
| Earnings Yield | 19.1% | 26.9% | · | 8.4% | 2.4% | -4.6% | · | 3.7% | 10.2% | 14.7% | · | 5.7% | 20.1% | 23.0% | · | 28.2% | |
| Annual Payout | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $411M | $359M | $310M | $331M | $392M |
| Operating Margin % | · | · | · | · | 95.7% |
| Net Income | $271M | $23M | $180M | $220M | $369M |
| Diluted EPS | $3.30 | $0.36 | $2.20 | $2.37 | $2.87 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | · | · | · | 1.0 |
| Current Ratio | · | · | · | · | 54.0 |
| Quick Ratio | · | · | · | · | 34.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | · | · | $364M |
Institutional owners (13F) 322 filers · $1.8B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
322
Value held
$1.8B
New positions
44
Exited positions
21
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 44 (-12 vs prior Q) | 21 (-13 vs prior Q) | 131 (+20 vs prior Q) | 83 (-1 vs prior Q) | +3K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $262,418,797 | 11,555,209 | 14.33% | Shares |
| VANGUARD GROUP INC | $158,262,890 | 7,917,103 | 8.64% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $102,062,559 | 4,494,053 | 5.57% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $95,842,400 | 4,220,273 | 5.24% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $91,669,642 | 4,036,532 | 5.01% | Shares |
| STATE STREET CORP | $74,216,371 | 3,268,004 | 4.05% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $71,719,384 | 3,158,053 | 3.92% | Shares |
| MILLENNIUM MANAGEMENT LLC | $57,708,585 | 2,541,109 | 3.15% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $47,125,306 | 2,074,709 | 2.57% | Shares |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $45,955,194 | 2,023,565 | 2.51% | Shares |
| Boston Partners | $43,777,396 | 1,927,959 | 2.39% | Shares |
| Sarissa Capital Management LP | $42,935,617 | 1,890,604 | 2.35% | Shares |
| BANK OF AMERICA CORP /DE/ | $37,873,400 | 1,667,697 | 2.07% | Shares |
| GOLDMAN SACHS GROUP INC | $36,792,312 | 1,620,093 | 2.01% | Shares |
| AMERICAN CENTURY COMPANIES INC | $34,020,579 | 1,498,044 | 1.86% | Shares |
| MARSHALL WACE, LLP | $33,027,585 | 1,454,319 | 1.80% | Shares |
| MORGAN STANLEY | $27,725,102 | 1,220,831 | 1.51% | Shares |
| ROYCE & ASSOCIATES LP | $26,631,790 | 1,172,690 | 1.45% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $26,146,182 | 1,151,307 | 1.43% | Shares |
| TWO SIGMA INVESTMENTS, LP | $23,455,047 | 1,032,807 | 1.28% | Shares |
| Qube Research & Technologies Ltd | $22,122,356 | 974,124 | 1.21% | Shares |
| DEUTSCHE BANK AG\ | $20,846,894 | 917,961 | 1.14% | Shares |
| NORTHERN TRUST CORP | $18,876,530 | 831,199 | 1.03% | Shares |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $18,857,793 | 830,374 | 1.03% | Shares |
| Invesco Ltd. | $16,640,071 | 732,720 | 0.91% | Shares |
| Nuveen, LLC | $15,158,154 | 667,466 | 0.83% | Shares |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $14,583,817 | 642,176 | 0.80% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $14,211,963 | 625,802 | 0.78% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $12,480,349 | 549,553 | 0.68% | Shares |
| UBS Group AG | $12,349,494 | 543,791 | 0.67% | Shares |
| Bank of New York Mellon Corp | $11,607,062 | 511,099 | 0.63% | Shares |
| Allianz Asset Management GmbH | $11,029,770 | 485,679 | 0.60% | Shares |
| Russell Investments Group, Ltd. | $10,867,504 | 478,533 | 0.59% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $10,654,079 | 469,136 | 0.58% | Shares |
| Assenagon Asset Management S.A. | $10,088,282 | 444,222 | 0.55% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $9,461,440 | 416,620 | 0.52% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $7,954,246 | 350,253 | 0.43% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $7,725,215 | 340,168 | 0.42% | Shares |
| Empowered Funds, LLC | $7,407,935 | 326,197 | 0.40% | Shares |
| FIRST TRUST ADVISORS LP | $6,489,314 | 285,747 | 0.35% | Shares |
| Balyasny Asset Management L.P. | $6,486,203 | 285,610 | 0.35% | Shares |
| Baird Financial Group, Inc. | $6,231,420 | 274,391 | 0.34% | Shares |
| FRANKLIN RESOURCES INC | $6,203,690 | 273,170 | 0.34% | Shares |
| JANE STREET GROUP, LLC | $6,153,002 | 270,938 | 0.34% | Shares |
| Edgestream Partners, L.P. | $6,116,893 | 269,348 | 0.33% | Shares |
| Uniplan Investment Counsel, Inc. | $6,000,241 | 264,211 | 0.33% | Shares |
| Public Sector Pension Investment Board | $5,471,021 | 240,908 | 0.30% | Shares |
| ASSETMARK, INC | $5,162,437 | 227,320 | 0.28% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $4,942,741 | 217,646 | 0.27% | Shares |
| AMERIPRISE FINANCIAL INC | $4,777,253 | 210,359 | 0.26% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Innoviva, Inc., Innoviva Strategic Opportunities LLC ×24 filings | May 13, 2026 | 82.70% | Amendment | · | SEC |
| Sarissa Capital Management LP, DENNER ALEXANDER J ×2 filings | March 17, 2025 | 4.70% | Amendment | · | SEC |
| Innoviva, Inc, Innoviva Strategic Opportunities LLC ×2 filings | Nov. 14, 2024 | · | Initial filing | · | SEC |
| OR ×4 filings | May 15, 2023 | · | Initial filing | · | SEC |
| April 5, 2021 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 53 insiders · 23 officers · 28 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Pavel Raifeld | Chief Executive Officer | Aug. 20, 2026 F | 284,799 | 0 | 0 | $0 |
| Stephen Basso | Chief Financial Officer | Aug. 20, 2026 F | 88,013 | 0 | 0 | $0 |
| Eric Desparbes | SVP and CFO | May 21, 2018 S | 373,081 | 0 | 0 | $0 |
| Marty Glick | Executive VP, Finance and CFO | Oct. 5, 2004 P | 267,805 | 0 | 0 | $0 |
| Matthew Ronsheim | Dr. Ronsheim is President of Innoviva Specialty Therapeutics, Inc. which is a wholly owned subsidiary of Innoviva Specialty Ther | May 20, 2024 F | 40,510 | 0 | 0 | $0 |
| Michael W Aguiar | President & Chief Exec Officer | Dec. 4, 2017 S | 980,907 | 0 | 0 | $0 |
| Marianne Zhen | Chief Accounting Officer | Aug. 20, 2026 F | 56,389 | 0 | 0 | $0 |
| Margaret Koziel | Chief Medical Officer | July 31, 2023 A | · | 0 | 0 | $0 |
| Geoffrey Hulme | Interim Principal Exec Officer | May 20, 2020 F | 46,251 | 0 | 0 | $0 |
| Theodore L Witek JR | Sr. VP & Chief Scientific Off. | Aug. 21, 2018 S | 247,767 | 0 | 0 | $0 |
| George B Abercrombie | Sr. VP & Chief Comm. Officer | Aug. 21, 2018 S | 285,479 | 0 | 0 | $0 |
| Michael E. Faerm | Sr VP & Chief Business Officer | Nov. 20, 2017 F | 279,422 | 0 | 0 | $0 |
| Junning Lee | Sr. VP, Technical Operations | Aug. 20, 2014 F | 262,198 | 0 | 0 | $0 |
| Mathai Mammen | SVP, Research & Early Clin Dev | Aug. 20, 2014 F | 334,040 | 0 | 0 | $0 |
| Bradford J Shafer | Sr VP, Gen. Counsel, Secretary | Aug. 20, 2014 F | 443,013 | 0 | 0 | $0 |
| Leonard M Blum | Sr VP, Chief Comm. Officer | June 16, 2014 A | 404,799 | 0 | 0 | $0 |
| Frank Pasqualone | Sr. Vice President, Operations | Jan. 23, 2014 A | 20,000 | 0 | 0 | $0 |
| Jeffrey David Jonker | Senior VP, Corp. & Bus. Dev. | Oct. 22, 2013 A | 15,000 | 0 | 0 | $0 |
| David L Brinkley | Head of Business Dev. | May 29, 2013 S | 48,749 | 0 | 0 | $0 |
| Michael Kitt | Sr. Vice President Development | June 4, 2008 M | 30,738 | 0 | 0 | $0 |
| Arthur L Campbell | Sr. VP, Technical Operations | Jan. 29, 2008 A | 5,376 | 0 | 0 | $0 |
| Patrick Pa Humphrey | Executive VP Research | Dec. 10, 2007 M | 54,310 | 0 | 0 | $0 |
| Gregory A Sturmer | Vice President Finance | Feb. 10, 2005 A | 290 | 0 | 0 | $0 |
| Josephine Linden | Director | May 18, 2026 A | 15,194 | 0 | 0 | $0 |
| Mark Dipaolo | Director | May 4, 2026 A | 140,492 | 0 | 0 | $0 |
| Derek A Small | Director | May 4, 2026 A | 45,035 | 0 | 0 | $0 |
| Sarah J. Schlesinger | Director | May 4, 2026 A | 140,492 | 0 | 0 | $0 |
| Jules Haimovitz | Director | May 4, 2026 A | 152,692 | 0 | 0 | $0 |
| Sapna Srivastava | Director | June 17, 2024 A | 44,096 | 0 | 0 | $0 |
| Odysseas D Kostas | Director | June 17, 2024 A | 122,625 | 0 | 0 | $0 |
| Deborah Birx | Director | May 22, 2023 A | 58,984 | 0 | 0 | $0 |
| George Bickerstaff | Director | April 25, 2022 A | 137,207 | 0 | 0 | $0 |
| Paul Pepe | Director | April 20, 2017 A | 73,805 | 0 | 0 | $0 |
| Barbara Gayle Duncan | Director | April 20, 2017 A | 52,318 | 0 | 0 | $0 |
| James L Tyree | Director | April 20, 2017 A | 70,554 | 0 | 0 | $0 |
| William H Waltrip | Director | April 20, 2017 A | 161,789 | 0 | 0 | $0 |
| Patrick G Lepore | Director | April 20, 2017 A | 58,278 | 0 | 0 | $0 |
| Terrence C Kearney | Director | April 24, 2015 A | 37,083 | 0 | 0 | $0 |
| Rick E Winningham | Director | Aug. 15, 2014 D | 825,391 | 0 | 0 | $0 |
| Henrietta Fore | Director | May 22, 2014 A | 33,000 | 0 | 0 | $0 |
| Robert V Gunderson JR | Director | May 22, 2014 A | 115,970 | 0 | 0 | $0 |
| George M Whitesides | Director | May 22, 2014 A | 606,377 | 0 | 0 | $0 |
| William D Young | Director | May 22, 2014 A | 83,935 | 0 | 0 | $0 |
| Peter S Ringrose | Director | May 22, 2014 A | 36,000 | 0 | 0 | $0 |
| Burton G Malkiel | Director | May 22, 2014 A | 40,000 | 0 | 0 | $0 |
| DRAZAN JEFFREY M | Director | May 1, 2012 S | 33,465 | 0 | 0 | $0 |
| Eve Elizabeth Slater | Director | April 25, 2007 A | · | 0 | 0 | $0 |
| Ronn Loewenthal | Director | May 2, 2006 M | 0 | 0 | 0 | $0 |
| Julian C. Baker | Director | April 26, 2006 A | 0 | 0 | 0 | $0 |
| GSK plc | · | May 20, 2021 S | 0 | 0 | 0 | $0 |
| Cathy Friedman | · | April 20, 2017 A | 73,805 | 0 | 0 | $0 |
| Arnold J Levine | · | March 21, 2014 M | 111,794 | 0 | 0 | $0 |
| VAGELOS P ROY | · | Dec. 23, 2009 M | 404,802 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 66 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 3.21% | 844,579 SH | Oct. 1, 2026 | Daily |
| SCOW · Pacer Funds Trust | 1.04% | 851 NS | July 31, 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.04% | 10,214 NS | July 31, 2026 | N-PORT |
| RNIN · EA Series Trust | 0.98% | 84,978 NS | July 31, 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0.83% | 69,613 SH | Oct. 1, 2026 | Daily |
| HSMV · First Trust Exchange-Traded Fund III | 0.63% | 10,579 NS | July 31, 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0.59% | 8,470 NS | July 31, 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0.57% | 52,620 NS | July 31, 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.53% | 5,773 SH | Oct. 1, 2026 | Daily |
| ROSC · Lattice Strategies Trust | 0.49% | 14,251 NS | July 31, 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0.46% | 84,775 SH | Aug. 19, 2026 | Daily |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0.46% | 61,253 SH | Oct. 1, 2026 | Daily |
| IHE · iShares Trust | 0.33% | 259,677 SH | Sept. 11, 2026 | Daily |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.29% | 192,060 NS | July 31, 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.24% | 68,619 NS | July 31, 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.19% | 11,742 NS | July 31, 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0.16% | 281,067 NS | July 31, 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.11% | 9,099 NS | July 31, 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.11% | 65,756 SH | Aug. 19, 2026 | Daily |
| DFSV · Dimensional ETF Trust | 0.11% | 425,619 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.10% | 5,119 SH | Oct. 1, 2026 | Daily |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.10% | 49,242 SH | Aug. 19, 2026 | Daily |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.09% | 10,402 SH | Oct. 1, 2026 | Daily |
| FSMD · FIDELITY COVINGTON TRUST | 0.09% | 110,972 NS | July 31, 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.09% | 245,491 SH | Aug. 19, 2026 | Daily |
| EBIT · Harbor ETF Trust | 0.08% | 455 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.08% | 96,256 SH | Oct. 1, 2026 | Daily |
| DFAT · Dimensional ETF Trust | 0.07% | 508,220 NS | July 31, 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.07% | 61,003 SH | Aug. 19, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.06% | 19,394 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.05% | 1,938,845 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.05% | 36,129 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.05% | 434,766 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.03% | 241,993 NS | July 31, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.03% | 1,021,419 SH | Aug. 19, 2026 | Daily |
| VFVA · VANGUARD WELLINGTON FUND | 0.03% | 10,116 SH | Aug. 19, 2026 | Daily |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.03% | 27,199 SH | Oct. 1, 2026 | Daily |
| ISCG · iShares Trust | 0.03% | 12,247 SH | Sept. 11, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.03% | 3,144 SH | Oct. 1, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 33,538 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 803,072 SH | Aug. 19, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.02% | 1,610,347 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.02% | 211,449 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.01% | 4,033 SH | Sept. 11, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.01% | 198,691 NS | July 31, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.01% | 53,396 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 6,691 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 1,559 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 8,987 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 20,704 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 24,791 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 103,511 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 19,040 SH | Sept. 3, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,231,526 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 52,609 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,178 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.00% | 16,651 SH | Aug. 19, 2026 | Daily |
| IJR · iShares Trust | · | 4,277,518 SH | Sept. 10, 2026 | Daily |
| IJT · iShares Trust | · | 392,937 SH | Sept. 9, 2026 | Daily |
| IJS · iShares Trust | · | 254,717 SH | Sept. 8, 2026 | Daily |
| IWN · iShares Trust | · | 710,119 SH | Sept. 11, 2026 | Daily |
| XJR · iShares Trust | · | 9,719 SH | Aug. 31, 2026 | Daily |
| SVAL · iShares Trust | · | 26,399 SH | Sept. 3, 2026 | Daily |
| ISCB · iShares Trust | · | 3,289 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 7,550 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 29,790 SH | Sept. 1, 2026 | Daily |
INVA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 11 analysts
BUY
Median target
$35.00
+70.7%
4 36.4%
Strong Buy
5 45.5%
Buy
1 9.1%
Hold
1 9.1%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-09-29Mean target $35.00 +70.7%
Now
Current price $20.50
Low$18.00
Mean$35.00
High$46.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| INVA | · | 6.1 | 14.7% | · | · | · |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| RAPP | $1.45B | -10.6 | · | · | -29.8% | · |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | · |
| PAHC | · | 12.9 | 17.1% | 6.6% | 29.7% | 33.8% |
| MAZE | $2.04B | -13.6 | · | · | -598.9% | · |
| XERS | $1.30B | · | 43.7% | 0.19% | -19.7% | · |
| KARD | · | · | · | · | · | · |
| OMER | $1.23B | -343.6 | · | · | 1.9% | · |
| AVLN | · | · | · | · | · | · |
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
BLUECHIP_DIP
Stopped out
risk 1
reward 3.12
entry
$21.13
R:R 3.12
BLUECHIP_DIP
Stopped out
risk 1
reward 5.00
entry
$22.18
R:R 5.00
BLUECHIP_DIP
Expired
risk 1
reward 4.79
entry
$21.36
R:R 4.79
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026